Use of antiresorptive drugs among older women: A case study in Wisconsin

被引:6
作者
Cline, RR
Mott, DA
机构
[1] Univ Minnesota, Coll Pharm, Dept Pharmaceut Care & Hlth Syst, Minneapolis, MN 55455 USA
[2] Univ Wisconsin, Sch Pharm, Sonderegger Res Ctr, Madison, WI 53706 USA
关键词
calcium regulators; data collection; drug use; estrogens; geriatrics; osteoporosis; women;
D O I
10.1093/ajhp/60.5.453
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The factors contributing to the use of antiresorptive therapies (ARTs) and differentiating the ARTs used were examined. A list of names of community-dwelling persons 65 years or older living in Wisconsin was obtained and 2100 individuals were selected (1050 men and 1050 women) to receive the 10-page survey instrument. the survey requested information on health status, prescription drugs versus self-treatment strategies, demographic characteristics, and status and type of prescription drug and medical insurance. Only the responses from female respondents were evaluated. Descriptive statistics were calculated for each variable. The simultaneous relationships among all variables were modeled sequentially using a binary logistic regression model and a multinomial regression model. Usable responses were received from 629 women, yielding an adjusted response rate of 59.9%; 169 (26.9%) reported current use of at least one ART, 110 (17.5%) reported using hormone replacement therapy (HRT), and 59 (9.4%) were using fewer ARTs. The typical respondent did not use any prescription medicines for the treatment or prevention of osteoporosis, was married and did not have a four-year college degree. Married, younger women with high medical care preferences scores were more likely to use antiresorptive agents. Married women were more likely to use HRT versus no treatment. A higher number of family practice physicians per 100,000 population reduced the likelihood of the use of any ART. Lower age was also related to the use of ARTs.
引用
收藏
页码:453 / 463
页数:11
相关论文
共 33 条
[21]   Postmenopausal hormone replacement therapy use by older Mexican-American women [J].
Newell, DA ;
Markides, KS ;
Ray, LA ;
Freeman, JL .
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2001, 49 (08) :1046-1051
[22]   ESTROGEN USE IN POSTMENOPAUSAL WOMEN [J].
PFEFFER, RI .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 1977, 105 (01) :21-29
[23]   Risks and benefits of estrogen plus progestin in healthy postmenopausal women - Principal results from the Women's Health Initiative randomized controlled trial [J].
Rossouw, JE ;
Anderson, GL ;
Prentice, RL ;
LaCroix, AZ ;
Kooperberg, C ;
Stefanick, ML ;
Jackson, RD ;
Beresford, SAA ;
Howard, BV ;
Johnson, KC ;
Kotchen, JM ;
Ockene, J .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 288 (03) :321-333
[24]  
SIEGEL J, AGING 21 CENTURY
[25]   Inadequate prescription-drug coverage for Medicare enrollees - A call to action [J].
Soumerai, SB ;
Ross-Degnan, D .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 340 (09) :722-728
[26]  
SPRAGGINS RE, 2002, WOMEN US PROFILE
[27]   Low rates of hormone replacement in visits to United States primary care physicians [J].
Stafford, RS ;
Saglam, D ;
Causino, N ;
Blumenthal, D .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1997, 177 (02) :381-387
[28]   Hormone replacement therapy and prevention of nonvertebral fractures - A meta-analysis of randomized trials [J].
Torgerson, DJ ;
Bell-Syer, SEM .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (22) :2891-2897
[29]  
*WISC DEP HLTH FAM, 1999, 1999 FAMILY HLTH SUR
[30]   USE OF MENOPAUSAL ESTROGENS AND MEDROXYPROGESTERONE IN THE UNITED-STATES, 1982-1992 [J].
WYSOWSKI, DK ;
GOLDEN, L ;
BURKE, L .
OBSTETRICS AND GYNECOLOGY, 1995, 85 (01) :6-10